NasdaqGS - Nasdaq Real Time Price USD

Progyny, Inc. (PGNY)

Compare
16.75 -7.69 (-31.47%)
As of 12:48 PM EDT. Market Open.
Loading Chart for PGNY
DELL
  • Previous Close 24.44
  • Open 17.60
  • Bid 12.76 x 200
  • Ask 16.82 x 400
  • Day's Range 13.93 - 17.95
  • 52 Week Range 13.93 - 42.08
  • Volume 11,676,976
  • Avg. Volume 1,380,555
  • Market Cap (intraday) 1.512B
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM) 26.59
  • EPS (TTM) 0.63
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 29.63

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

www.progyny.com

563

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PGNY

View More

Performance Overview: PGNY

Trailing total returns as of 9/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PGNY
54.95%
S&P 500
19.99%

1-Year Return

PGNY
51.97%
S&P 500
28.51%

3-Year Return

PGNY
72.79%
S&P 500
29.11%

5-Year Return

PGNY
24.07%
S&P 500
89.36%

Compare To: PGNY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PGNY

View More

Valuation Measures

Annual
As of 9/18/2024
  • Market Cap

    2.21B

  • Enterprise Value

    1.96B

  • Trailing P/E

    38.79

  • Forward P/E

    13.89

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.16

  • Price/Book (mrq)

    4.84

  • Enterprise Value/Revenue

    1.73

  • Enterprise Value/EBITDA

    26.55

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.54%

  • Return on Assets (ttm)

    6.45%

  • Return on Equity (ttm)

    13.56%

  • Revenue (ttm)

    1.13B

  • Net Income Avi to Common (ttm)

    62.75M

  • Diluted EPS (ttm)

    0.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    262.19M

  • Total Debt/Equity (mrq)

    4.35%

  • Levered Free Cash Flow (ttm)

    156.67M

Research Analysis: PGNY

View More

Company Insights: PGNY

Research Reports: PGNY

View More

People Also Watch